PubMed HealthSearch

PubMed · 7123485

Acute mesenteric ischemia.

Abstract

Forty-nine patients with acute mesenteric ischemia have been treated during the past 15 years. The overall mortality rate was 65%; the prognosis varied with the cause of disease. None of the 12 patients with primary thrombosis of the mesenteric arteries, 5 of 14 with spontaneous embolization, and 2 of 4 with arterial occlusion subsequent to diagnostic angiography survived. Seven of 11 patients with primary mesenteric venous thrombosis and 2 of 7 patients in whom mesenteric ischemia was related to low flow unassociated with occlusion of either the major arteries or veins survived. The only patient with occlusive arterial vasculitis survived. Thirty-one of these 49 patients presented with peritoneal signs. The serum glutamic oxaloacetic transaminase, lactic dehydrogenase, and creatine phosphokinase levels were significantly elevated in patients with nonocclusive ischemia and less elevated in patients with arterial or venous thrombosis. By contrast, the enzyme levels were frequently normal in patients with arterial embolization. Angiography was diagnostic in all four patients who were evaluated with this procedure--three patients with arterial embolization and one patient with nonocclusive ischemia. This procedure should be used more frequently, especially when embolization is suspected. The value of reexploration was assessed. There were 17 reexplorations, with only three contributing to survival (17.7%). Two patients with mesenteric venous thrombosis and one patient with arterial embolization benefited from resectional therapy during reexploration. The study emphasizes that diagnostic criteria, therapy, and prognosis can be correlated with the etiologic factor.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S M Sachs, J H Morton, S I Schwartz. 1982. Acute mesenteric ischemia.. https://pubmed.ncbi.nlm.nih.gov/7123485/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide.

We applied the animal model of H. pylori lipopolysaccharide-induced gastritis to assess the effect of antiulcer agent, sulglycotide, on the mucosal inflammatory responses by analyzing the interplay between the activity of a key apoptotic caspase, caspase-3, epithelial cell apoptosis, and the expression of constitutive (cNOS) and inducible (NOS-2) nitric oxide synthase. H. pylori lipopolysaccharide applied intragastrically elicited within 4 days a pattern of mucosal responses resembling that of acute gastritis. This was accompanied by an 11.2-fold increase in epithelial cell apoptosis, a 6.5-fold induction in mucosal expression of NOS-2 and a 2.2-fold decline in cNOS, and a 5.4-fold increase in caspase-3 activity. Treatment with sulglycotide led to a 56.7% reduction in the extent of mucosal inflammatory changes elicited by H. pylori lipopolysaccharide and an 88.3% decrease in the epithelial cells apoptosis. Furthermore, this effect of sulglycotide was associated with a 51% decrease in mucosal expression of caspase-3 activity, a 73.7% decline in NOS-2, and a 64.1% increase in cNOS. The findings suggest that sulglycotide suppresses the H. pylori-induced mucosal inflammatory responses by up-regulating cNOS and interfering with the events propagated by NOS-2 and caspase-3.

Acute Disease

Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.

Optimal immunological control of cutaneous herpes simplex virus type 1 (HSV-1) infections initiated in the hind footpad of C57BL/6 (B6, H-2b) mice is dependent upon the presence of functional HSV-1-specific T lymphocytes. The class I MHC-restricted, CD8+ T cell subpopulation is involved in the clearance of infectious HSV-1 from the skin and limiting HSV-1 replication and spread within the peripheral nervous system. However, the frequency of HSV-1-specific CTL precursors (CTLp), as a measure of potential anti-viral CD8+ T cell function, is relatively low compared with other acute viral infections. To gain insight into the basis for this low functional frequency, changes in the CD8+ T cell subpopulation phenotype associated with activation and differentiation were investigated. Analysis of the phenotypic changes showed that HSV-1-specific CTLp were found predominantly within a subpopulation of CD8+ T cells expressing high levels of CD44 (CD44high) and high levels of the IL-2 receptor alpha-chain (CD25high). A second activated subpopulation of CD8+ T cells expressing the CD44high CD25low phenotype did not contain detectable HSV-1-specific CTLp, even after the addition of HSV-1-infected stimulator cells as a source of an exogenous Ag. These data suggested that HSV-1-specific CD8+ T cells must increase expression of CD25 before attaining the potential to become CTL effector cells. These findings also indicated that the up-regulation of CD44 alone is not sufficient to identify precisely HSV-1-specific CD8+ T cells.

Acute Disease